CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Parmax Pharma Ltd

Parmax Pharma Ltd

BSE 540359 PARMAX INE240T01014
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 30 trading days

14 filings · 5 material · busiest 2026-08-14

What it files

General3 SAST2 Open Offer2 Newspaper Publication1 Insider / SAST1 Board Outcome1 Results1 Change in Management1

Filings

14 in the window

  1. 24 August 2026

    General

    Post Offer Advertisement

    Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulations 18(12) of the Securities and Exchange Board of India ....

    Company Update / General View filing →

  2. 24 August 2026

    General

    Intimation Of Reclassification Of Promoters Under Regulation 31A Of SEBI (LODR) Regulations, 2015

    Intimation of Reclassification of Promoters under Regulations 31A of SEBI (LODR) Regulations, 2015

    Company Update / General View filing →

  3. 17 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Chandulal Shah, Sunil Chinubhai Shah & PACs

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  4. 17 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Alkesh Mahasukhlal Gopani & Others

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  5. 17 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper publication of extract of Financial results of quarter ended June 30, 2026

    Company Update / Newspaper Publication View filing →

  6. 14 August 2026

    Insider / SAST

    Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Shah & Others

    Insider Trading / SAST / Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011 View filing →

  7. 14 August 2026

    Board Outcome

    Board Meeting Outcome for Approval Of Unaudited Financial Results For Quarter Ended 30.06.2026

    Outcome of Board Meeting as per attached

    Board Meeting / Outcome of Board Meeting View filing →

  8. 14 August 2026

    Results

    Results For Quarter Ended June 30, 2026

    Results for quarter ended June 30, 2026

    Result / Financial Results View filing →

  9. 14 August 2026

    Change in Management

    Change in Management

    Appointment of Mr. Dhiren Shah, Mr. Sunil Shah as an Additional Directors and recommendation of Ms. Anjana Shah, Ashish Shah as an Independent Directors subject to prior approval of shareholders ....

    Company Update / Change in Management View filing →

  10. 11 August 2026

    Board Meeting

    Board Meeting Intimation for Approval Of Quarterly Financial Results For Quarter Ended June 30, 2026

    Parmax Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve quarterly financial results for ....

    Board Meeting / Board Meeting View filing →

  11. 29 July 2026

    Open Offer

    Updates on Open Offer

    Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Offer Opening Pre-Offer Advertisement to the Public Shareholders of Parmax Pharma ....

    Company Update / Open Offer View filing →

  12. 27 July 2026

    Open Offer

    Updates on Open Offer

    Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Recommendations of the Committee of Independent Directors ('IDC') to the Public ....

    Company Update / Open Offer View filing →

  13. 22 July 2026

    General

    Letter of Offer

    Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").

    Company Update / General View filing →

  14. 16 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate for quarter ended June 30, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →